USPTO serial 79359706
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment for immunotherapy; diagnostic reagents for cancer; cell for immunotherapy; cancer therapy preparations; cell therapy preparations; vaccines | ACTIVE | — |
| 010 | Medical apparatus and instruments | ACTIVE | — |
| 040 | Processing of therapeutic cell and lymphocyte; processing of cell for immunotherapy and lymphocyte; processing of medical materials used for immunotherapy; processing of medical materials; providing information relating to processing of medical materials; culture, processing or proliferation of cell or lymphocyte for test, inspection or research; custom processing and providing of human cell | ACTIVE | — |
| 042 | Test, inspection or research on drugs used for immunotherapy; test, inspection or research of pharmaceutical preparations; inspection or research on therapeutic methods by processing cells or lymphocyte; test, inspection or research on therapeutic methods for disease; Immunological test, inspection or research; test, inspection or research on cell; test or research on medical materials used for immunotherapy; testing or research of medical materials; testing or research of medical apparatus and instruments; conducting clinical trials of pharmaceutical preparations; providing information relating to conducting clinical trials of pharmaceutical preparations; custom cultivation of human cell; test, inspection, research or development for medical services in the field of cancerous diseases | ACTIVE | — |
| 044 | Consulting on regenerative medicine; providing information relating to medical services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 19, 2025 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 2, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 2, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 1, 2024 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 1, 2024 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 1, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 10, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 15, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 15, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 26, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 25, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 15, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 13, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 9, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 5, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |